Overview
- 5 inspections across 5 sites are on record.
- 22 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2021-04-14.
At a glance
Inspections
5
Sites
5
Observations
22
Career since
Dec 2019
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Cosmetic Group USA, Inc. | 14 Apr 2021 | Human Drugs | View 483 → |
| Airgas USA, LLC | 12 Mar 2021 | Human Drugs | View 483 → |
| Genentech Inc | 17 Mar 2020 | Human Drugs | |
| Intarcia Therapeutics, Inc. | 17 Jan 2020 | Human Drugs | View 483 → |
| DLC Laboratories, Inc. | 12 Dec 2019 | Human Drugs | View 483 → |
Sites inspected
Cosmetic Group USA, Inc.Sun Valley, United States1 insp.
Airgas USA, LLCVentura, United States1 insp.
Genentech IncVacaville, United States1 insp.
Intarcia Therapeutics, Inc.Hayward, United States1 insp.
DLC Laboratories, Inc.Paramount, United States1 insp.
Co-investigators
Investigators who share inspections with this person.
Jeffrey P Raimondi2 shared
Uttaniti Limchumroon2 shared
Dogbeda F Mackenzie1 shared
Scott N Lim1 shared
Nicholas L Hunt1 shared
Chiaochun J Wang1 shared
Full investigator report
Get the verbatim findings behind Kouros Kangarli's 22 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site